Navigation Links
Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital
Date:4/1/2008

Patient enrollment begins for trial of airway bypass procedure to treat advanced widespread emphysema

WINFIELD, Ill., April 1, 2008 /PRNewswire-USNewswire/ -- Researchers at Suburban Lung Associates and the Chicago Chest Center recently announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational treatment for advanced widespread emphysema. The trial focuses on airway bypass, a minimally invasive bronchoscopic procedure designed to help patients with emphysema/COPD (chronic obstructive pulmonary disease) breathe more easily.

Central DuPage Hospital is the only site for the EASE trial in the Chicago area.

"Airway bypass could be groundbreaking because it is a potential non-surgical treatment for the patient with diffuse emphysema," states Dr. Kevin Kovitz, interventional pulmonologist and principal investigator of the study at the Central DuPage Hospital site. "Emphysema, which permanently destroys lung function, is such a devastating disease, and any potential new treatment option could offer substantial relief to the millions who struggle with each breath."

During the airway bypass procedure, new openings are created in the airway wall connecting the damaged lung tissue to the natural airway. These pathways are supported and kept open by Exhale(R) Drug-Eluting Stents manufactured by Broncus Technologies, Inc. Patients could see an immediate improvement in shortness of breath.

Emphysema, a type of COPD, is a chronic, progressive and irreversible lung disease characterized by the destruction of lung tissue. The loss of the lungs' natural elasticity and the collapse of airways in the lung combine to leave emphysema sufferers unable to get air out of their lungs. As a result, patients have to work very hard just to breathe, making normal activities, like walking, eating or even bathing, difficult. There are few treatment options for most patients with emphysema and there is
'/>"/>

SOURCE Central DuPage Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
2. Emphasys Medical Announces Positive Data From Pivotal Trial for Patients With Emphysema
3. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
4. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
5. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
6. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
11. New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... addition of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses ... in the United States . Reimbursement ... studied. Thorough product analyses for more than 73 SMBG ...
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Scientific Corporation (NYSE: BSX ) today announced ... of Los Gatos, California.  The transaction follows the definitive ... terms of the agreement, Boston Scientific paid $193 million ... equity not already owned by Boston Scientific.  Additional payments ...
... 4, 2011 ERT (Nasdaq: ERES ), announced ... and Keith Schneck, the Company,s Chief Financial Officer, are scheduled ... at 9:30 AM PST on January 13, 2011 in San ... by visiting the Company,s corporate website at http://www.ert.com . ...
Cached Medicine Technology:Boston Scientific Completes Acquisition of Sadra Medical 2Boston Scientific Completes Acquisition of Sadra Medical 3Boston Scientific Completes Acquisition of Sadra Medical 4ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011 2
(Date:12/26/2014)... Cooking and warming equipment ... 5. This score reflects slightly positive negotiation conditions for ... low switching costs and a low level of price ... availability of substitutes for cooking and warming equipment and ... aluminum, key inputs in the production process of this ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 Plugin and template ... TransPack Volume 5 Plugin for Final Cut Pro X. , ... hard light tool to pull off an industry professional look” ... get their hands on TransPack Volume 5, a new level ... is a set of over 50 Final Cut Pro X ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the Best ... 2014. The awards program, created in 2000, is one ... the country. The program is a public/private partnership between ... Economic Development, the Pennsylvania State Council of the Society ... Journal. , Charlie Wilson, Vice President of ...
(Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... have discovered a new gene mutation they say causes ... Swiss family with Parkinson,s disease, using advanced DNA sequencing technology. ... of Human Genetics , was led by neuroscientists at the ... U.S., Canada, Europe, United Kingdom, Asia and the Middle East. ...
... July 15 (HealthDay News) -- After undergoing the weight-loss ... routine can help patients continue to lose weight and ... didn,t know until now whether morbidly obese bariatric surgery ... Dr. Abhimanyu Garg, chief of nutrition and metabolic diseases ...
... , FRIDAY, July 15 (HealthDay News) -- Injection drug ... regardless of what types of drugs they use, according ... users suffer higher rates of abuse, dependence and other ... help treatment programs specialize their care to target these ...
... for Medical Systems Biology (BIMSB) of the Max Delbrck ... be the first academic research institution in Continental Europe ... of single DNA molecules in real time. The SMRT ... high-throughput technologies. The researchers of the BIMSB will use ...
... HealthDay Reporter , THURSDAY, July 14 (HealthDay News) -- ... include smoking has dropped for the fifth year in a row, ... 72 percent drop since 2005 in smoking images in movies rated ... to 595 in 2010. In addition, the average number of smoking ...
... By Alan Mozes HealthDay Reporter , THURSDAY, July ... virus responsible for many well-known illnesses in humans and animals ... in another, according to researchers. This "jumping" virus is ... pneumonia and many other illnesses in humans. Until now -- ...
Cached Medicine News:Health News:Mayo researchers: Genetic mutation linked to Parkinson's disease 2Health News:Rigorous Exercise May Boost Benefits of Weight-Loss Surgery 2Health News:Injection Drug Users Most in Need of Treatment, Study Says 2Health News:Novel DNA sequencer for MDC's systems biology 2Health News:Less Lighting Up in Movies Aimed at Kids 2Health News:Less Lighting Up in Movies Aimed at Kids 3Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 2Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 3Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 4
... Continuous centralized monitoring with wireless connectivity, ... feature for the S/5 monitoring system that ... Monitor and S/5 FM to the S/5 ... ,Wireless operation is a flexible way of ...
... for anesthesia., ,The S/5 Anesthesia Monitor (AM) ... and upgradeable solution for routine to the most ... parameter modules, you can choose the set of ... And when your needs evolve, the modularity of ...
... in the operating and recovery room, ... for combined haemodynamic and airway gas monitoring ... anesthesia care units. The Cardiocap II is ... the basic haemodynamic measurements. Two of the ...
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Medicine Products: